Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France
Overall survival from diagnosis of multiple myeloma, according to world... | Download Scientific Diagram
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
Overall survival of multiple myeloma based on clinical stage at... | Download Scientific Diagram
Blog Archives - Multiple Myeloma - Survival Rate Statistics by Hospital
Trends in overall survival and costs of multiple myeloma, 2000–2014 | Leukemia
Figure 1 from Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. | Semantic Scholar
Retrospective analysis of 264 multiple myeloma patients
Overall survival of 3664 patients with multiple myeloma, according to... | Download Scientific Diagram
Progression-free and overall survival for high-risk patients with relapsed or refractory multiple myeloma (RRMM) who received carfilzomib-based regimens
A Multiple Myeloma Roundtable: Treatment Trends and Recent Clinical Advances
Cureus | Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients
![The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial - The](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2f9746ff-a56a-4d1f-9fa7-5e6b9f11a6ee/gr1_lrg.jpg "The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial - The")
The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial - The
Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial - The Lancet
Improved long-term survival in multiple myeloma up to the age of 80 years | Leukemia
Myeloma survival statistics | Cancer Research UK
Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011–2019 oncology clinic electronic he
Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population - Clinical Lymphoma, Myeloma and Leukemia
Survival Of Multiple Myeloma Patients Significantly Increases Over Last Decade
Daratumumab, Lenalinomide, and Dexamethasone for Myeloma | NEJM Resident 360
Overall survival (OS) in 253 patients with multiple myeloma... | Download Scientific Diagram
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
